Development of a compact anti-BAFF antibody in Escherichia coli

Applied Microbiology and Biotechnology

Volumn 73, Issue 1, 2006, Pages 151-157

  Cao, Peng ^a,b   Zhang, Shuangquan ^a   Gong, Zhunan ^a   Tang, Xiangming ^a   Cao, Meng ^a   Hu, Yunlong ^c  

^a NANJING NORMAL UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c Nanjing Chuanbo Biotechnology Incorporation   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BIOASSAY; ESCHERICHIA COLI; GENES; GENETIC ENGINEERING; IMMUNOLOGY;

AUTOIMMUNE DISEASES; GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANTIBODIES;

BACTERIUM ANTIBODY; BAFF ANTIBODY; COMPLEMENT COMPONENT C1Q; DODECYL SULFATE SODIUM; IMMUNOGLOBULIN G1; PROTEIN A; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANTIBODY; BACTERIUM; DEVELOPMENTAL STAGE; IMMUNE SYSTEM; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; PROTEIN;

ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; PROTEIN BINDING; WESTERN BLOTTING;

ANTIBODIES; AUTOIMMUNE DISEASES; B-CELL ACTIVATING FACTOR; BLOTTING, WESTERN; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPLEMENT C1Q; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MOLECULAR WEIGHT; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; STAPHYLOCOCCAL PROTEIN A;

ESCHERICHIA COLI;

EID: 33750341637     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-006-0432-4     Document Type: Article

References (25)

1. Adams GP, McCartney JE, Tai MS, Oppermann H, Huston JS, Stafford WF, Bookman MA, Fand I, Houston LL, Weiner LM (1993) Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv. Cancer Res 53:4026-4034
2. Baker KP, Edwards BM, Main SH, Choi GH, Wager RE, Halpern WG, Lappin PB, Riccobene T, Abramian D, Sekut L, Sturm B, Poortman C, Minter RR, Dobson CL, Williams E, Carmen S, Smith R, Roschke V, Hilbert DM, Vaughan TJ, Albert VR (2003) Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis Rheum. 48:3253-3265
3. Borsi L, Balza E, Bestagno M, Castellani P, Carnemolla B, Biro A, Leprini A, Sepulveda J, Burrone O, Neri D, Zardi L (2002) Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin. Int J Cancer 102:75-85
4. Burton DR (1985) Immunoglobulin G: functional sites. Mol Immunol 22:161-206
5. Cao P, Xia Z, Song W, Zhang S (2005a) Neutralizing human anti-B-cell-activating factor of the TNF family (BAFF) scFv selected from phage antibody library. Immunol Lett 101:87-94
6. Cao P, Mei JJ, Diao ZY, Zhang SQ (2005b) Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli. Protein Expr Purif 41:199-206
7. Cao P, Tang XM, Guan ZB, Diao ZY, Zhang SQ (2005c) Production and characterization of a bacterial single-chain antibody fragment specific to B-cell-activating factor of the TNF family. Protein Expr Purif 43:157-164
8. Laemmli UK (1970) Cleavage of structural proteins during assembly of the heat of bacteriophage T4. Nature 277:680-685
9. Isenman DE, Dorrington KJ, Painter RH (1975) The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement. J Immunol 114:1726-1729
10. Mackay F, Browning JL (2002) BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2:465-475
11. Melchers F (2003) Actions of BAFF in B cell maturation and its effects on the development of autoimmune disease. Ann Rheum Dis 62:225-227
12. Milenic DE, Yokota T, Filpula DR, Finkelman MA, Dodd SW, Wood JF, Whitlow M, Snoy P, Schlom J (1991) Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res 51:6363-6371
13. Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O, Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Greenfield W, Ruben SM, Olsen HS, Fikes J, Hilbert DM (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285:260-263
14. Mukhopadhyay A, Ni J, Zhai Y, Yu GL, Aggarwal BB (1999) Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-κB, and c-Jun NH2-terminal kinase. J Biol Chem 274:15978-15981
15. Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS, Sosnovtseva S, Carrell JA, Feng P, Giri JG, Hilbert DM (2001) Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97:198-204
16. Owens RJ, Young RJ (1994) The genetic engineering of monoclonal antibodies. J Immunol Methods 168:149-165
17. Ramanujam M, Davidson A (2004) The current status of targeting BAFF/BlyS for autoimmune diseases. Arthritis Res Ther 6:197-202
18. Reff ME, Heard C (2001) A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications. Crit Rev Oncol Hematol 40:25-35
19. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, Scott ML (2001) An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111-2114
20. Schneider P, Tschopp J (2003) BAFF and the regulation of B cell survival. Immunol Lett 88:57-62
21. Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, Tschopp J (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189:1747-1756
22. Shu HB, Hu WH, Johnson H (1999) TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol 65:680-683
23. Studier FW (1991) Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system. J Mol Biol 219:37-44
24. Tribouley C, Wallroth M, Chan V, Paliard X, Fang E, Lamson G, Pot D, Escobedo J, Williams LT (1999) Characterization of a new member of the TNF family expressed on antigen presenting cells. Biol Chem 380:1443-1447
25. Yokota T, Milenic DE, Whitlow M, Schlom J (1992) Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 52:3402-3408